Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc C.PMED

Alternate Symbol(s):  PMEDF

Predictmedix AI Inc. is a Canada-based provider of rapid health screening and remote patient care solutions globally. The Company’s Safe Entry Stations, powered by artificial intelligence AI, use multispectral cameras to analyze physiological data patterns and predict a variety of health issues, including infectious diseases, such as COVID-19, impairment by drugs or alcohol, fatigue, or various mental illnesses. Its remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. Its solutions include Infectious Disease Screening, Impairment Screening, and Mobilewellbeing. The Infectious Disease Screening screen for COVID-19, its variants, and other infectious diseases. It offers cannabis and alcohol impairment screening. Mobilewellbeing is a software platform with patient monitoring devices. The Company’s autonomous, non-invasive, no-contact solutions detect symptoms before they spread through workplace.


CSE:PMED - Post by User

Post by partystockeron Nov 06, 2021 3:16pm
210 Views
Post# 34096141

$CULT to IPO very soon

$CULT to IPO very soon

CULT Food Sciences continues to place itself at the forefront of the lab-grown meat analogues and alternatives field. Their recent appointment of pharmacologist Paul Burridge to their advisory board should really give them an edge on innovation. 


Burridge is the principal of the Burridge Lab at Northwestern University, which currently researches the use of induced pluripotent stemcells (iPSC) in the use of cultivated meats. 


Burridge’s insights into this bleeding edge technology should really give $CULT and their subsidiaries the upper hand in developing meat analogues and pushing them to market. 


$CULT has an impressive portfolio of companies ranging from producers of consumer and high-end meat products, to synthetic honey and plant based egg products. 


With a focus on environmental impact and sustainability, $CULT is set up to be an industry-leading ethical platform for investors to gain exposure to the synthetic foods market. 


I’m really excited for CULT to IPO and will be waiting patiently for them to do so.

 
<< Previous
Bullboard Posts
Next >>